INTRODUCTION {#sec1-1}
============

Erectile dysfunction (ED) is more prevalent in men with diabetes mellitus (DM). The morbidity rate of ED among diabetic men varies from 35% to 90% due to different population and ages.[@ref1][@ref2] Aside from the heavy burden, diabetes mellitus induced erectile dysfunction (DMED), pathogenic manifestations involving endothelial injury, neuropathy, microvascular and fibrous-muscular alterations is usually more serious and difficult to treat than nondiabetic.[@ref3][@ref4] The oxidation of low-density lipoproteins and overproduction of oxygen-free radicals induced by hyperglycemia may lead to smooth muscle dysfunction.[@ref5] Hyperglycemia can result in mitochondrial fragmentation and apoptosis of endothelial cells.[@ref6] Moreover, DMED is highly associated with nerve growth factor (NGF) deficiency and impaired vascular endothelial growth factor (VEGF) signaling.[@ref2][@ref4] Phosphodiesterase type 5 inhibitor (PDE5i) was considered to be the first-line pharmacologic therapy for ED since 1998; however, PDE5i showed less efficacy in treating DMED.[@ref3]

Recently, many experimental approaches for DMED have emerged, including insulin treatment,[@ref7] antioxidant therapy,[@ref8] low energy shock wave therapy,[@ref9] stem cells, and gene therapy.[@ref10][@ref11] Among these strategies, stem cell-based therapy is considered to be promising due to its ability to recover functional cells and tissues. For choosing the candidate stem cells, adipose-derived stem cells (ADSCs) have been proposed as one of the most suitable types. Similar to bone marrow stem cells (BMSCs), ADSCs possess the ability of self-renewing and differentiation.[@ref12] ADSCs can be collected in abundant quantities and harvested by a minimally invasive procedure. In addition, the successful transplantation of allogeneic ADSCs indicated a low immunogenicity of the cells.[@ref13] A growing body of evidence suggested the usage of ADSCs in several ED models.[@ref14][@ref15][@ref16] Of interest, the benefits of ADSCs for ED appear to be related to growth factor and cytokine activity.[@ref14] However, the single-cell-based injection is known as low cellular survival which is necessary to long-term success. Adult stem cells might lose many properties in ordinary adherent culture.[@ref17] Numerous reports noticed that adult stem cells cultured as spheroids which were scaffold-free could increase the therapeutic potential.[@ref18][@ref19] Our previous study showed that ADSCs-based microtissues (MTs) improved erectile function through neuroprotection in a rat model of cavernous nerve injury.[@ref20] In this study, the efficacy of ADSCs and ADSC-based MTs was compared for the treatment of ED in streptozotocin (STZ)-induced diabetic rats and histologic changes were examined.

MATERIALS AND METHODS {#sec1-2}
=====================

 {#sec2-1}

### Animals {#sec3-1}

A total of 64 male Sprague-Dawley rats aged 8 weeks old (body weight: 270--310 g) were purchased from the Animal Center of Peking University. The Committee for Animal Care and Use of Peking University approved the experiments. After harvesting of paratesticular fat, 56 rats were fasted for 16 h, and then intraperitoneally injected with STZ (60 mg kg^−1^; Sigma-Aldrich, St. Louis, MO, USA). Blood glucose levels were measured at 72 h after STZ injection using a blood glucose meter (B. Braun, Melsungen, Germany). Of the 56 rats, 54 (96.43%) were diabetic with a fasting glucose concentration higher than 300 mg dl^−1^. An intraperitoneal injection of phosphate buffer solution (PBS) was administered to 8 rats as control group. At 8 weeks after STZ injection, apomorphine (100 μg kg^−1^; Sigma-Aldrich, St. Louis, MO, USA) was used to screen the diabetic rats.[@ref16] DMED was present in 48 of the 54 (88.89%) rats. The 48 DMED rats were numbered and randomly assigned to three groups: intracavernous (IC) injection of PBS (*n* = 8, the DM + PBS group), ADSCs (*n* = 20, the DM + ADSCs group), and MTs (*n* = 20, the DM + MTs group). The control group also received an IC injection of PBS. ADSCs were labeled with the chloromethylbenzamido derivative 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate (CM-Dil; Molecular Probes, Carlsbad, CA, USA) and tracked at days 1, 7, and 14 (*n* = 4) after injection. At day 28, rats in each group were examined for ED before the harvest of tissues.

### ADSCs isolation and MTs generation {#sec3-2}

ADSCs were isolated from paratesticular fat and cultured as previous standardized method.[@ref21][@ref22] In brief, all the animals underwent lower abdominal midline incision and bilateral resection of paratesticular adipose tissue. The adipose tissue was rinsed with PBS containing 1% Streptomycin and Penicillin, chopped into small pieces, and incubated in 0.075% collagenase type IA (Sigma-Aldrich, St. Louis, MO, USA) for 80 min. The top lipid part was removed and the liquid part was centrifuged at 1000 ×*g* at room temperature for 10 min. Then, the remaining cells were suspended in low glucose Dulbecco\'s modified Eagle\'s medium (DMEM, Hyclone, Logan, UT, USA) supplemented with 1% Streptomycin and Penicillin and 10% fetal bovine serum (FBS, HyClone, Logan, UT, USA). After filtered through a 100-μm cell strainer, the suspension was planted in a 10-cm dish and cultured at 37°C in 5% CO~2~. MTs were generated with a hanging drop method according to our previous study.[@ref20] When reaching approximately 80% confluence, ADSCs in each dish were centrifuged and resuspended in 1.2 ml DMEM. Then, ADSCs (1 × 10^4^ cells in 30 μl) were dropped onto the cover of new dishes (40 drops per dish), 5 ml PBS was added to each dish, and the cover was carefully placed back on the dish. Dishes were kept at 37°C in 5% CO~2~ for 3 days.

### ADSCs and MTs characteristics {#sec3-3}

Osteogenic and adipogenic differentiations were performed on both ADSCs and MTs. ADSCs and 3-day-old MTs were seeded in 6-well tissue culture plates and cultured in rat adipose-derived stem cell osteogenic or adipogenic differentiation medium (Cyagen, Santa Clara, CA, USA). We replaced the medium every 3 days with the differentiating time of 21 days, removed the differentiation medium, and rinsed the well with PBS. The cells were fixed with 4% formaldehyde solution for 30 min, and then stained with Alizarin Red or Oil Red O working solution for 30 min. After rinsing, the cells were visualized under light microscope (Leica, Heidelberg, Germany).

Cell lysate from ADSCs or MTs was mixed with biotinylated detection antibodies, and then incubated with a rat cytokine antibody array membrane (R&D systems, Minneapolis, MN, USA) which containing capture antibodies of 29 different target proteins. After washing, the membrane was exposed using chemiluminescent detection reagents.

### IC injection {#sec3-4}

Under aseptic conditions, the determined DMED and normal rats were anesthetized with 10% chloral hydrate (300 mg kg^−1^). The penis was exposed in each group, and a 24-gauge needle was used to inject a total of 1 × 10^6^ ADSCs or 100 MTs (1 × 10^4^ ADSCs per MT) in 100 μl PBS or only 100 μl PBS into the corpus cavernosum (CC).[@ref20] An elastic band was applied to the base of the penis and the pressure was maintained for 2 min after the injection.

### Measurement of erectile function {#sec3-5}

Erectile function was determined by intracavernosal pressure (ICP) and mean arterial pressure (MAP) 4 weeks postinjection. Under 10% chloral hydrate, the major pelvic ganglion (MPG) and cavernous nerves (CN) were exposed through a midline laparotomy. The penile was exposed by removing overlying skin and ischiocavernosus muscle. One of the 24-gauge needles that were connected to PE-50 tubes with heparinized saline (250 IU ml^−1^) was inserted into the left carotid to measure MAP. The other one was inserted into corpus cavernosum (CC) to measure ICP. PE-50 tubes were connected to the data acquisition system (MP150, BIOPAC Systems Inc., Goleta, CA, USA). The CNs were stimulated using a stainless steel bipolar hook electrode with the following parameters: 20 Hz, pulse width of 0.2 ms, 1.5 mA, for 50 s. The ratio of maximal ICP (mm Hg) to MAP (mm Hg) was calculated.

### Immunofluorescence staining {#sec3-6}

For immunofluorescence (IF) staining, the penile tissue (midshaft portion) and entire major pelvic ganglia (MPG) were fixed in fresh 4% paraformaldehyde, and then were immersed in 30% sucrose in PBS overnight at 4°C.[@ref15][@ref20] The fixed tissues and 3-day-old MTs were cryoembedded in optimal cutting temperature compound (Sakura Finetek, Torrance, CA, USA) and cut into 5 μm sections before mounting on slides. MPGs were cut crosswise in the middle. After permeabilization and blocking, the slides were incubated with primary antibodies, including rabbit anti-neuronal nitric oxide synthase (nNOS, 1:200; Abcam, Cambridge, UK), rabbit anti-NGF (1:400; Abcam, Cambridge, UK), rabbit anti-VEGF (1:200; Abcam, Cambridge, UK), rabbit anti-α smooth muscle actin (α-SMA, 1:1000; Abcam, Cambridge, UK), rabbit anti-von Willebrand factor (vWF, 1:2000; Abcam, Cambridge, UK), rabbit anti-CD31 (1:400; Abcam, Cambridge, UK), rabbit anti-CD34 (1:200; Abcam, Cambridge, UK), rabbit anti-CD105 (1:400; Abcam, Cambridge, UK), and mouse anti-tumor necrosis factor-induced protein-6 (TSG-6, 1:200; Abcam, Cambridge, UK) at 4°C overnight. At room temperature, the sections were rinsed and incubated with Alexa Fluor-594 conjugated secondary antibodies (Invitrogen, Carlsbad, CA, USA). Nuclei were stained by 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen) for 5 min. For tracking the labeled cells, the slides of penile tissues were stained with DAPI only. Slides were visualized under a fluorescence microscope (Leica, Heidelberg, Germany).

### Western blotting {#sec3-7}

Total proteins of rat penis, ADSCs, and 3-day-old MTs were extracted by mechanical homogenization in lysis buffer containing protease and phosphatase inhibitors (Sigma-Aldrich, St. Louis, MO, USA). Proteins were quantified using a bicinchoninic acid (BCA) protein assay kit (Thermo Scientific, Waltham, MA, USA). A volume of 20 μg sample of each protein was electroseparated in a 10% sodium dodecyl sulfate-polyacrylamide gel and transferred to a polyvinylidene fluoride membrane (Millipore Corporation, Bedford, MA, USA). For incubation, the primary antibodies were rabbit anti-NGF (1:400), rabbit anti-nuclear factor kappa-B (NF-κB, 1:2000), rabbit anti-VEGF (1:200), rabbit anti-α-SMA (1:2000), rabbit anti-nNOS (1:400), mouse anti-tumor necrosis factor-induced protein-6 (TSG-6, 1:200; all from Abcam, Cambridge, UK), and mouse anti-glyceraldehyde phosphate dehydrogenase (GAPDH, 1:10 000; Santa Cruz Biotechnology, Santa Cruz, CA, USA). After incubation with the appropriate secondary antibody (1:2000; Santa Cruz Biotechnology), membranes were exposed using chemiluminescent detection reagents. Images were obtained with a C-digit machine (LI-COR Biosciences, Cambridge, UK).

### Image and statistical analysis {#sec3-8}

Histomorphometric results were representative values (*n* = 5 per group) and analyses for slides were performed using Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD, USA). Western blotting (WB) and rat cytokine array results were analyzed with ImageJ (National Institutes of Health, Bethesda, MD, USA). Statistical analyses were performed with the SPSS 19.0 (SPSS Inc., Chicago, IL, USA). Results were expressed as mean ± standard deviation (s.d.) and values of *P* \< 0.05 were considered statistically different. Multiple comparisons between groups were done using one-way analysis of variance followed by a *post hoc* analysis with the Tukey--Kramer test while a comparison between two groups was performed by *t*-test.

RESULTS {#sec1-3}
=======

 {#sec2-2}

### Rats blood glucose and body weight {#sec3-9}

One rat in DM + PBS group and two rats in DM + ADSCs group were dead and abandoned during the experiment. The final blood glucose levels of STZ-induced diabetic rats were remarkably higher compared to PBS-treated control rats (*P* \< 0.05). The final weights of diabetic rats were markedly lower than normal rats (*P* \< 0.05). Among DM + PBS, DM + ADSCs, and DM + MTs groups, blood glucose levels and body weights were not statistically different ([**Table 1**](#T1){ref-type="table"}).

###### 

Body weight and blood glucose variables

![](AJA-19-91-g001)

### Characterization of ADSCs and MTs {#sec3-10}

ADSCs cultured in a hanging drop gradually aggregated into a single central spheroid (**[Figure 1a](#F1){ref-type="fig"}**), and the diameter of spheroid reduced around 175.11 ± 5.58 μm at the third day (**[Figure 1b](#F1){ref-type="fig"}**). CM-Dil-labeled cells were showed in ADSCs or MTs. Immunofluorescence results showed that CD31 and CD34 were negative in MTs while CD105, vWF, NGF, VEGF, and TSG-6 were expressed in MTs (**[Figure 1c](#F1){ref-type="fig"}**). Osteogenic and adipogenic differentiations demonstrated that both ADSCs and MTs have the potential for multipotency (**[Figure 1d](#F1){ref-type="fig"}**).

![Characterization of the ADSCs and MTs. **(a)** Microscopy showing 10 000 ADSCs in a hanging drop gradually formed a stable spheroid with smooth edge and round shape. **(b)** The diameter of MTs was 253.67 ± 14.63 µm at 24 h, 191.90 ± 7.63 µm at 48 h, 175.12 ± 5.52 µm at 72 h, 165.66 ± 4.42 µm at 96 h, and 154.88 ± 4.15 µm at 120 h. Insert bar = 100 µm. **(c)** ADSCs and MTs were labeled with CM-Dil. MTs did not express CD31 and CD34 but expressed CD105, vWF, VEGF, NGF, and TSG-6. Original magnification: ×200. **(d)** Photomicrographs showing osteogenic (Alizarin Red staining) and adipogenic (Oil Red O staining) differentiations of ADSCs and MTs. Insert bar = 50 µm.](AJA-19-91-g002){#F1}

### The disappearance of labeled cells in ADSCs- and MT-injected rats {#sec3-11}

The CM-Dil-labeled cells were tracked in ADSCs- and MT-injected rats at days 1, 7, and 14 post-IC injection (**[Figure 2a](#F2){ref-type="fig"}**). As they were showed by integral optical density (IOD), cells disappeared rapidly in ADSC-injected rats compared with MT-injected rats (**[Figure 2b](#F2){ref-type="fig"}**). At days 7 and 14, cells remained retaining in MT-injected rats while very few cells could be observed in ADSC-injected rats (*P* \< 0.05).

![Time-dependent disappearance of IC-injected cells. **(a)** Representative images of CM-Dil-labeled cells retained in corpus cavernosum at days 1, 7, and 14 postinjection in ADSC- and MT-injected rats. Original magnification: Left, ×200 and right, ×1000. **(b)** Quantitative data of labeled cells between two groups are expressed as integrated optical density (IOD) of CM-Dil-positive area in corpus cavernosum. \**P* \< 0.05 compared with DM + ADSCs group.](AJA-19-91-g003){#F2}

### Erectile function assessment {#sec3-12}

Diabetic rats in DM + PBS group showed significant decreases in both maximum ICP and ICP to MAP ratios compared to the normal rats (*P* \< 0.05). ADSCs treatment partially ameliorated erectile dysfunction compared with PBS-treated diabetic rats (*P* \< 0.05) (**[Figure 3a](#F3){ref-type="fig"}**) while MT-injected rats displayed significant improvements compared with ADSC-injected rats (*P* \< 0.05). There were no striking differences in MAP between groups (**Figure [3a](#F3){ref-type="fig"}** and **[3b](#F3){ref-type="fig"}**).

![Erectile function of each group. **(a)** Representative images of intracavernous pressure (ICP) and mean arterial pressure (MAP). Horizontal bar below ICP represents 50 s of stimulate duration. **(b)** Left: Results of peak ICP increase of ADSCs- and MTs-treated rats. Right: Results of ratio ICP to mean MAP of each group. \**P* \< 0.01 when compared with DM + PBS group. &*P* \< 0.05 when compared with DM + ADSCs group.](AJA-19-91-g004){#F3}

### Smooth muscle and endothelium contents in cavernous tissue {#sec3-13}

IF staining and WB analysis of α-SMA expression in penis showed a significant decrease of smooth muscle content in PBS-treated diabetic rats ([**Figure 4**](#F4){ref-type="fig"}). Both ADSCs and MTs treatments restored the smooth muscle content (*P* \< 0.05). Surprisingly, MTs treatment displayed a better recovery with the higher smooth muscle density (*P* \< 0.05). The endothelium content was indicated by vWF-positive area in CC and markedly decreased in rats of DM + PBS group compared with rats in control group (*P* \< 0.05). After IC injection of ADSCs, the endothelium content was increased to some degree (*P* \< 0.05). After MTs treatment, the endothelium in cavernous tissue was better restored compared with ADSC-injected rats (*P* \< 0.05) (**Figure [4a](#F4){ref-type="fig"}** and **[4c](#F4){ref-type="fig"}**). Meanwhile, WB results showed that VEGF expression in penis was higher in MT-injected rats than that of ADSC-injected rats (*P* \< 0.05) or PBS-injected diabetic rats (*P* \< 0.05) (**Figure [4d](#F4){ref-type="fig"}** and **[4f](#F4){ref-type="fig"}**).

![Smooth muscle and endothelium content. **(a)** Representative histological images of smooth muscle and endothelium in corpus cavernosum of each group indicated by α-SMA and vWF, respectively. Original magnification: ×100, ×200. Quantitative data of smooth muscle **(b)** and endothelium **(c)** are shown in right column bar graph. **(d)** Protein levels of α-SMA and VEGF are quantified as α-SMA/GAPDH **(e)** and VEGF/GAPDH **(f)** and expressed as mean ± standard deviation. \**P* \< 0.05 compared with DM + PBS group. &*P* \< 0.05 compared with DM + ADSCs group.](AJA-19-91-g005){#F4}

### nNOS expressions in dorsal penile nerves and major pelvic ganglia {#sec3-14}

IF and WB results showed that the induced DM caused significant decreases of nNOS content in dorsal penile nerves (DPN) (*P* \< 0.05) and nNOS-positive neurons in MPG (*P* \< 0.05). Rats in DM + ADSCs group showed a partial recovery of nNOS expression (*P* \< 0.05). Obviously, MTs injection restored more nNOS-positive nerves and neurons compared with ADSCs injection (*P* \< 0.05) ([**Figure 5**](#F5){ref-type="fig"}). Meanwhile, NGF expression in penis was higher in DM + MTs group than that of DM + ADSCs group or DM + PBS group (*P* \< 0.05) (**Figure [5d](#F5){ref-type="fig"}** and **[5f](#F5){ref-type="fig"}**).

![nNOS expression in dorsal penile nerve and major pelvic ganglia. **(a)** Representative images of nNOS expression in the dorsal penile nerve (DPN) and nNOS-positive neurons in major pelvic ganglia (MPG), original magnification: ×200. Graph summarizing the quantitative data of nNOS content in DPN **(b)** and nNOS-positive cells in MPG **(c)**. **(d)** Western blot analysis of nNOS and NGF contents in penis. Protein levels are quantified by nNOS/GAPDH **(e)** and NGF/GAPDH **(f)** in each column and expressed as mean ± standard deviation. \**P* \< 0.05 compared with DM + PBS group. ^&^*P* \< 0.05 compared with DM + ADSCs group.](AJA-19-91-g006){#F5}

### Rat cytokine array analysis of ADSCs and MTs {#sec3-15}

Rat cytokine array showed that cytokine-induced neutrophil chemoattractant 1 (CINC-1), cholinergic neurotrophic factor (CNTF), L-Selectin, and chemokine CCL5 were expressed only in ADSCs lysate, lipopolysaccharide-inducible CXC chemokine (LIX) and interleukin-1ra (IL-1ra) expressions were higher in ADSCs lysate than those of MTs lysate (*P* \< 0.05), TIMP metallopeptidase inhibitor 1 (TIMP-1), and soluble intercellular cell adhesion molecule-1 (sICAM-1), and VEGF expressions were higher in MTs lysate (*P* \< 0.05) (**[Figure 6a](#F6){ref-type="fig"}**). WB results also demonstrated that VEGF expression was higher in MTs compared with ADSCs (*P* \< 0.05), NGF and TSG-6 were only expressed in MTs, and NF-κB expression was lower in MTs (*P* \< 0.05) (**Figure [6b](#F6){ref-type="fig"}** and **[6c](#F6){ref-type="fig"}**). Meanwhile, NF-κB expression in penis was higher in PBS-treated diabetic rats compared with rats in control group (*P* \< 0.05) and ADSCs treatment did not affect the level of NF-κB (*P* \> 0.05) while MTs treatment markedly decreased NF-κB expression (*P* \< 0.05) (**Figure [6d](#F6){ref-type="fig"}** and **[6e](#F6){ref-type="fig"}**).

![Rat cytokine array analysis of ADSCs and MTs lysates. **(a)** Rat cytokine array analysis of MTs and ADSCs lysates showed that nine proteins were detected in ADSCs lysate while five proteins were detected in MTs lysate. Protein levels are showed as relative pixel density and quantified by positive control. \**P* \< 0.05 compared with ADSCs lysate. **(b)** Western blot analysis of VEGF, NGF, TSG-6, and NF-κB contents in ADSCs and MTs. **(c)** Protein levels are quantified by VEGF/GAPDH, NGF/GAPDH, TSG-6/GAPDH, and NF-κB/GAPDH. \**P* \< 0.05 compared with ADSCs. **(d)** Western blot analysis of NF-κB expression in penis of each group and **(e)** protein levels are quantified by NF-κB/GAPDH. \**P* \< 0.05 compared with DM + PBS or DM + ADSCs group. ^\#^*P* \> 0.05 compared with DM + PBS group.](AJA-19-91-g007){#F6}

DISCUSSION {#sec1-4}
==========

Nitrergic nerves, endothelium, and smooth muscles are crucial for normal penile erection. The released nitric oxide (NO) from endothelium or nerve terminals stimulates the production of cyclic guanosine monophosphate (cGMP), and then the gradually accumulated cGMP helps dilate corporal smooth muscle, facilitate blood supply, and cause erection.[@ref23] Macrovasculopathy, microvasculopathy, and endothelial dysfunction are the major vasculopathy limiting the blood flow in the penis. Microvascular disease in diabetes also causes nerve ischemia resulting in peripheral neuropathy and autonomic neuropathy which play important roles in DMED. In the present study, reductions of smooth muscle and endothelium density in CC were observed in PBS-injected diabetic rats. Moreover, diabetic rats showed neuronal degeneration through markedly reduced nNOS content in DPN and nNOS-positive neurons in MPG. These results are consistent with previous findings about diabetic rats.[@ref10][@ref24]

ADSCs are adult stem cells with multipotency and low immunogenicity.[@ref22] Moreover, they have been applied to repair muscle tissues and restore tissue vascularization.[@ref25] As for ED therapy, independent groups have investigated the feasibilities and advantages of ADSCs in rat models of DMED, cavernous nerve injury, and Peyronie\'s disease.[@ref16][@ref26][@ref27] These results were encouraging but the traditional single-cell-based injection was relative preliminary, and the therapeutic potential was hampered by poor retention rate due to the blood flow. In this regard, MTs generated by a hanging drop method was seen as superior to single cell strategy. To examine whether IC injection of MTs has a better retention in diabetic rats, we labeled ADSCs with CM-Dil before treatment. The results showed that the labeled cells disappeared rapidly in CC of ADSC-injected rats as very limited amount was detected 2 weeks after IC injection while more CM-Dil-positive cells could be observed in MT-injected rats. These are consistent with the previous studies that rare cells could be tracked in cavernous tissue after transplantation and stem cells preprocessed as MTs could promote the cell retention and engraftment.[@ref15][@ref19] The higher local retention could change the extracellular compartment of local tissue and might contribute to the greater improvement of erectile function.

Besides, many works have proposed that the transplanted cells played a part in CC might not through direct differentiation into local cell types but through the secretion of cytokines and growth factors.[@ref14][@ref16][@ref28] In this study, WB results demonstrated that the expressions of VEGF and NGF were higher in MTs than those of ADSCs. As a proangiogenic factor, VEGF has multiple functions including stimulates proliferation, inhibits apoptosis, and promotes cell survival.[@ref11] Impaired VEGF signaling pathway was closely related to endothelial dysfunction and was thought to be a possible cause for ED in diabetes.[@ref2] NGF is a type of neurotrophins that promote neural survival and differentiation. It has been revealed that NGF expression in target organs was decreased and the axonal transport of NGF was delayed in diabetic rats.[@ref29] VEGF and NGF expressions in penis were better augmented in MT-injected rats than those of ADSC-injected rats. Smooth muscle and endothelium density accompanied with nNOS content were increased more in MTs-treated rats than those of ADSCs-treated rats. These results demonstrated that MTs injection had better effects on vascularization and neuroprotection.

ADSCs expressed higher levels of the inflammatory proteins CINC-1, CCL5, and IL-1ra[@ref30] than MTs, indicating that MTs have anti-inflammatory activity. Indeed, MTs, but not ADSCs, expressed TSG-6, a multifunctional protein with an anti-inflammatory effect.[@ref31] Importantly, TSG-6 induced anti-inflammatory activity through the inhibition of transcript factor NF-κB, which regulated many key genes related to immune and inflammatory responses.[@ref32] WB results also showed the lower NF-κB expression in MTs compared with ADSCs, all of these indicated the anti-inflammatory ability of MTs. To examine whether IC injection of ADSCs or MTs inhibits local inflammation, we detected NF-κB expression in penis of each group. Interestingly, WB results demonstrated that diabetes-induced inflammation in penis and ADSCs treatment did not affect the local inflammation while the inflammatory state in CC was partially recovered by IC injection of MTs. This could be another reason for the higher efficiency of MTs treatment. Further studies should be carried out to check the systemic inflammation by measuring both pro- and anti-inflammatory cytokines to better understand the anti-inflammatory function of MTs.

Culturing adult stem cells in adherent monolayer could not truly recreate the specialized microenvironment which was known as stem cell niche *in vivo* and might limit the potential of transplanted cells.[@ref33] Therefore, mimicking the niche composition might help enhance the regenerative potential of ADSCs expanding *in vitro*.[@ref34] Moreover, subculturing of stem cells upon long-term *in vitro* would lead to phenotypes change and some abilities lose.[@ref19][@ref35] In this study, both used single ADSCs and ADSCs dissociated from MTs possessed the adipogenic and osteogenic differentiation potential indicating that ADSCs retained their properties when cultured as MTs. Similarly, previous work on mesenchymal stem cells demonstrated that cells in spheroids retained most of the surface epitopes and differentiation potential.[@ref18] Nutrient deprivation and "microgravity" are the possible stimulating factors related to the changes of cells cultured as MTs. It is possible that stem cells cultured in MTs can contact closely with each other and the large amount of the cells ensures the quality of cell signaling and secretion. This can be partly supported by the higher expression of ICAM-1 in MTs since ICAM-1 was important in stabilizing cell-cell interactions.[@ref36]

IC injection of ADSCs-based MTs resulted in a better improvement of erectile function in diabetic rats than single-cell ADSCs injection, and the greater therapeutic effects through enhanced paracrine abilities were supported by indirect evidence in our study. Moreover, the erectile function and histologic changes associated were not completely recovered only by ADSCs or MTs treatment. The diabetes status is relative complex and the hyperglycemia may cause sustained damages; therefore, blood glucose controlled by insulin combined with MTs injection will be a more promising way for DMED treatment. Investigations should be carried out in more ED animal models and to better evaluate the therapeutic effects and safety for potential clinical application.
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